AAAAAA
Results: 1-25/39
Authors:
Yee, RE
Irwin, I
Milonas, C
Stout, DB
Huang, SC
Shoghi-Jadid, K
Satyamurthy, N
Delanney, LE
Togaski, DM
Farahani, KF
Delfani, K
Janson, AM
Phelps, ME
Langston, JW
Barrio, JR
Citation: Re. Yee et al., Novel observations with FDOPA-PET imaging after early nigrostriatal damage, MOVEMENT D, 16(5), 2001, pp. 838-848
Authors:
Petzinger, GM
Quik, M
Ivashina, E
Jakowec, MW
Jakubiak, M
Di Monte, D
Langston, JW
Citation: Gm. Petzinger et al., Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate, MOVEMENT D, 16(2), 2001, pp. 202-207
Authors:
Farrer, M
Chan, P
Chen, R
Tan, L
Lincoln, S
Hernandez, D
Forno, L
Gwinn-Hardy, K
Petrucelli, L
Hussey, J
Singleton, A
Tanner, C
Hardy, J
Langston, JW
Citation: M. Farrer et al., Lewy bodies and parkinsonism in families with parkin mutations, ANN NEUROL, 50(3), 2001, pp. 293-300
Authors:
Togasaki, DM
Tan, L
Protell, P
Di Monte, DA
Quik, M
Langston, JW
Citation: Dm. Togasaki et al., Levodopa induces dyskinesias in normal squirrel monkeys, ANN NEUROL, 50(2), 2001, pp. 254-257
Authors:
Steen, RG
Taylor, JS
Langston, JW
Glass, JO
Brewer, VR
Reddick, WE
Mages, R
Pivnick, EK
Citation: Rg. Steen et al., Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: Relationship of macrocephaly to T1 relaxation changes andstructural brain abnormalities, AM J NEUROR, 22(5), 2001, pp. 810-817
Authors:
Tanner, CM
Goldman, SM
Lyons, KE
Aston, DA
Tetrud, JW
Welsh, MD
Langston, JW
Koller, WC
Citation: Cm. Tanner et al., Essential tremor in twins - An assessment of genetic vs environmental determinants of etiology, NEUROLOGY, 57(8), 2001, pp. 1389-1391
Authors:
Mahoney, DH
Cohen, ME
Friedman, HS
Kepner, JL
Gemer, L
Langston, JW
James, HE
Duffner, PK
Kun, LE
Citation: Dh. Mahoney et al., Carboplatin is effective therapy for young children with progressive opticpathway tumors: A Pediatric Oncology Group phase II study, NEURO-ONCOL, 2(4), 2000, pp. 213-220
Authors:
Langston, JW
Tan, LCS
Citation: Jw. Langston et Lcs. Tan, Juvenile Parkinsonism: a term in search of an identity, EUR J NEUR, 7(5), 2000, pp. 465-466
Authors:
Walter, AW
Gajjar, A
Reardon, DA
Thompson, SJ
Langston, JW
Jones-Wallace, D
Kun, LE
Heideman, RL
Citation: Aw. Walter et al., Tamoxifen and carboplatin for children with low-grade gliomas: A pilot study at St. Jude Children's Research Hospital, J PED H ONC, 22(3), 2000, pp. 247-251
Authors:
Reddick, WE
Russell, JM
Glass, JO
Xiong, XP
Mulhern, RK
Langston, JW
Merchant, TE
Kun, LE
Gajjar, A
Citation: We. Reddick et al., Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation, MAGN RES IM, 18(7), 2000, pp. 787-793
Authors:
Langston, JW
Quik, M
Petzinger, G
Jakowec, M
Di Monte, DA
Citation: Jw. Langston et al., Investigating levodopa-induced dyskinesias in the Parkinsonian primate, ANN NEUROL, 47(4), 2000, pp. S79-S89
Authors:
Steen, RG
Xiong, XP
Mulhern, RK
Langston, JW
Wang, WC
Citation: Rg. Steen et al., Subtle brain abnormalities in children with sickle cell disease: Relationship to blood hematocrit - Reply, ANN NEUROL, 47(2), 2000, pp. 280-280
Authors:
Kaste, SC
Jenkins, JJ
Pratt, CB
Langston, JW
Haik, BG
Citation: Sc. Kaste et al., Retinoblastoma: Sonographic findings with pathologic correlation in pediatric patients, AM J ROENTG, 175(2), 2000, pp. 495-501
Authors:
He, L
Di Monte, DA
Langston, JW
Quik, M
Citation: L. He et al., Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and levodopa treatment, NEUROSCIENC, 99(4), 2000, pp. 697-704
Authors:
Quik, M
Police, S
He, L
Di Monte, DA
Langston, JW
Citation: M. Quik et al., Expression of D-3 receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: Effect of levodopa treatment, NEUROSCIENC, 98(2), 2000, pp. 263-273
Authors:
Quik, M
Polonskaya, Y
Gillespie, A
Lloyd, GK
Langston, JW
Citation: M. Quik et al., Differential alterations in nicotinic receptor alpha 6 and beta 3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration, NEUROSCIENC, 100(1), 2000, pp. 63-72
Authors:
McGrew, DM
Irwin, I
Langston, JW
Citation: Dm. Mcgrew et al., Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice, NEUROTOXICO, 21(3), 2000, pp. 309-312
Authors:
Langston, JW
Tanner, CM
Citation: Jw. Langston et Cm. Tanner, Selegiline and Parkinson's disease - It's deja vu - again, NEUROLOGY, 55(12), 2000, pp. 1770-1771
Authors:
Snow, BJ
Vingerhoets, FJG
Langston, JW
Tetrud, JW
Sossi, V
Calne, DB
Citation: Bj. Snow et al., Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism, J NE NE PSY, 68(3), 2000, pp. 313-316
Authors:
Yee, RE
Huang, SC
Stout, DB
Irwin, I
Shoghi-Jadid, K
Togaski, DM
DeLanney, LE
Langston, JW
Satyamurthy, N
Farahani, KF
Phelps, ME
Barrio, JR
Citation: Re. Yee et al., Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity inMPTP-treated squirrel monkeys: In vivo and in vitro investigations, J NEUROCHEM, 74(3), 2000, pp. 1147-1157
Authors:
Thiffault, C
Langston, JW
Di Monte, DA
Citation: C. Thiffault et al., Increased striatal dopamine turnover following acute administration of rotenone to mice, BRAIN RES, 885(2), 2000, pp. 283-288
Authors:
He, L
Di Monte, DA
Langston, JW
Quik, M
Citation: L. He et al., Autoradiographic analysis of dopamine receptor-stimulated [S-35]GTP gamma S binding in rat striatum, BRAIN RES, 885(1), 2000, pp. 133-136
Authors:
Kadota, RP
Kun, LE
Langston, JW
Burger, PC
Cohen, ME
Mahoney, DH
Walter, AW
Rodman, JH
Parent, A
Buckley, E
Kepner, JL
Friedman, HS
Citation: Rp. Kadota et al., Cyclophosphamide for the treatment of progressive low-grade astrocytoma: Apediatric oncology group phase II study, J PED H ONC, 21(3), 1999, pp. 198-202
Authors:
Chow, E
Jenkins, JJ
Burger, PC
Reardon, DA
Langston, JW
Sanford, RA
Heideman, RL
Kun, LE
Merchant, TE
Citation: E. Chow et al., Malignant evolution of choroid plexus papilloma, PED NEUROS, 31(3), 1999, pp. 127-130
Authors:
Burkhard, PR
Shale, H
Langston, JW
Tetrud, JW
Citation: Pr. Burkhard et al., Quantification of dyskinesia in Parkinson's disease: Validation of a novelinstrumental method, MOVEMENT D, 14(5), 1999, pp. 754-763